top of page

Last week, a Republican congressman appeared on a Fox News podcast to express cautious optimism that the Senate will green-light his House-passed amendment to the National Defense Authorization Act (NDAA), which, if enacted, would allow the secretary of defense to approve grants for research into the therapeutic potential of psychedelics for active duty military members with PTSD.

“I am hopeful. I am not sure there’s serious opposition. I think there’s a lack of education on this,” Rep. Dan Crenshaw (R-TX), a military veteran himself, said on the Kennedy Saves the World podcast.

In the interview, the congressman also discussed the random encounters that inspired him to first look into psychedelics, evidence that the substances can alleviate PTSD symptoms and the differences between his own amendment and similar measures put forward by Reps. Alexandria Ocasio-Cortez (D-NY) and Matt Gaetz (R-FL).

Crenshaw noted that he hopes that “at least” one of the amendments will make it through the Senate version of the NDAA “and we can make this law.”

Listen to Crenshaw discuss his psychedelics amendment below:

Crenshaw recounted a series of serendipitous conversations that compelled him to research and take action on the issue.

One evening roughly a year ago, the congressman had dinner with a veteran friend who told him about his positive experiences with ibogaine. Later that same night, he ran into Jonathan Lubecky, the Veterans & Governmental Affairs Liaison for the Multidisciplinary Association for Psychedelic Studies (MAPS), in the elevator of his apartment building.

Lubecky told him about his own previous suicide attempts and how psychedelics improved his mental health.

“I was like, how is it that I am getting the story from two different people that don’t know each other? In the same night? I just thought it was strange,” Crenshaw—who says he has not tried psychedelics himself—recalled.

In the podcast interview, Crenshaw referenced a Department Veteran Affairs study showing that MDMA had transformative effects on veterans with PTSD. ”It’s really incredible. So the data is really showing up here,” he said.

He additionally mentioned the growing number of military veterans who have undergone ibogaine treatment in Mexico, with extremely positive results.

“These are not enjoyable experiences, they are therapies,” he pointed out, pushing back on any notion that his effort is about recreational drug use.

“The changes within [veterans] were just so obvious and dramatic that you couldn’t ignore something like this,” he added.

Former Navy SEAL & congressman @RepDanCrenshaw (R-TX) joins @KennedyNation on the #KSTW podcast to discuss some of the cutting-edge treatment options for former members of the military who suffer from PTSD, including the use of psychedelics: https://t.co/qjGnLKkqDppic.twitter.com/wBCBgRnA0f

— FOX News Radio (@foxnewsradio) August 6, 2022


Crenshaw filed a similar amendment for last year’s version of NDAA, but the House Rules Committee did not allow it to advance to a floor vote.

The two-term lawmaker has otherwise consistently voted against marijuana and drug policy reform measures in Congress, including two prior Ocasio-Cortez amendments that were aimed at removing barriers to research on the benefits of psychedelics.

His home state of Texas recently enacted a law to require officials to study the therapeutic potential of psilocybin, MDMA and ketamine for military veterans.

Crenshaw follows in the footsteps of another high-profile Texas Republican who has recently advocated for veterans’ access to psychedelics. Former governor and Secretary of Energy Rick Perry has became a vocal proponent on the issue.

In the podcast interview, Crenshaw acknowledged that both Ocasio-Cortez and Gaetz have introduced similar psychedelics amendments to his own. What distinguishes Crenshaw’s amendment from AOC’s, which was also approved by the House last month? It covers more drugs, the congressman said. “I think AOC’s was simply psilocybin and MDMA. I added Ibogaine and DMT to that,” Crenshaw noted.

With respect to his colleague on the other side of the aisle, Crenshaw admitted that any communications and coordination on the two similar proposals occurred via staff members.

“A lot of our base doesn’t want to see us work together,” he said. “I hate that. It’s stupid that that’s the case, but it is.”

SXSW Opens Voting On Nearly 100 Marijuana And Psychedelics Panels For 2023 Festival

Photo courtesy of YouTube/Joe Rogan Experience.

 
 
 

Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page